BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7162034)

  • 1. Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats.
    Ishikawa S; Schrier RW
    Kidney Int; 1982 Dec; 22(6):587-93. PubMed ID: 7162034
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of plasma arginine vasopressin in the impaired water diuresis of isolated glucocorticoid deficiency in the rat.
    Mandell IN; DeFronzo RA; Robertson GL; Forrest JN
    Kidney Int; 1980 Feb; 17(2):186-95. PubMed ID: 7382268
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular effects of arginine vasopressin, angiotensin II, and norepinephrine in adrenal insufficiency.
    Ishikawa S; Schrier RW
    Am J Physiol; 1984 Jan; 246(1 Pt 2):H104-13. PubMed ID: 6364835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of two analogues of arginine-vasopressin (ornithine-vasopressin and desamino-D-arginine-vasopressin) on kidney function in sheep.
    Yesberg NE; Henderson M; Budtz-Olsen OE
    Q J Exp Physiol Cogn Med Sci; 1978 Apr; 63(2):179-88. PubMed ID: 247535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin analogs that antagonize antidiuretic responses by rats to the antidiuretic hormone.
    Sawyer WH; Pang PK; Seto J; McEnroe M; Lammek B; Manning M
    Science; 1981 Apr; 212(4490):49-51. PubMed ID: 7209515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiuretic antagonism and agonism of 1-deamino-pentamethylene-2-D-phenylalanine-4-isoleucine-arginine vasopressin in rats with diabetes insipidus.
    Vilhardt H; Lundin S
    J Endocrinol; 1987 Mar; 112(3):439-42. PubMed ID: 3559452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the role of antidiuretic hormone in the inhibition of acute water diuresis in adrenal insufficiency and the effects of gluco- and mineralocorticoids in reversing the inhibition.
    Green HH; Harrington AR; Valtin H
    J Clin Invest; 1970 Sep; 49(9):1724-36. PubMed ID: 5449709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water diuresis in the volume expanded glucocorticoid-deficient dog.
    Levi J; Grinblat J; Kleeman CR
    Isr J Med Sci; 1973 Apr; 9(4):429-37. PubMed ID: 4709226
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasopressin antagonism in the squirrel monkey (Saimiri sciureus).
    Kinter LB; Churchill S; Stassen FL; Moore M; Huffman W
    J Pharmacol Exp Ther; 1987 Jun; 241(3):797-803. PubMed ID: 3598903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and therapeutic utility of vasopressin antagonists in rats.
    Kinter LB; Dytko G; Ashton D; McDonald J; Huffman W; Stassen F
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S36-43. PubMed ID: 2434770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the vasopressin antagonist d(CH2)5 Tyr(Et)VAVP on diuresis in rat.
    László FA; Csáti S; Baláspiri L; Manning M
    Acta Med Hung; 1984; 41(1):65-73. PubMed ID: 6739224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and renal function study of Val-Asp-(Arg8)-vasopressin.
    Chan YL; Peterson CA; Ting YF; Smith CW
    Life Sci; 1981 Jan; 28(4):415-9. PubMed ID: 7219053
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of V2 antagonist on clearance of arginine vasopressin by isolated perfused rat kidneys.
    Keeler R; Sato AK; Claybaugh JR; Wilson N
    Am J Physiol; 1991 Sep; 261(3 Pt 2):R665-9. PubMed ID: 1887953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the vasopressin antagonist d/CH2/5Tyr/Et/VAVP on the antidiuretic action of exogenous and endogenous vasopressin.
    László FA; Csáti S; Baláspiri L
    Acta Endocrinol (Copenh); 1984 May; 106(1):52-5. PubMed ID: 6730854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous antidiuretic activity of antidiuretic hormone antagonists.
    Kinter LB; Caltabiano S; Huffman WF
    Biochem Pharmacol; 1993 May; 45(9):1731-7. PubMed ID: 8494530
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of hyponatraemia and cerebral oedema by the vasopressin antagonist d/CH2/5Tyr/Et/VAVP in rats treated with pitressin tannate.
    László FA; Csáti S; Baláspiri L
    Acta Endocrinol (Copenh); 1984 May; 106(1):56-60. PubMed ID: 6730855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A specific antagonist of vasopressin produced plasma hyperosmolality and reduced ischemic-induced cerebral edema in rats.
    Tang AH; Ho PM
    Life Sci; 1988; 43(5):399-403. PubMed ID: 3398706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin-dependent upregulation of aquaporin-2 gene expression in aged rats with glucocorticoid deficiency.
    Saito T; Saito T; Kasono K; Otani T; Tamemoto H; Kawakami M; Sasaki S; Ishikawa S
    Acta Physiol (Oxf); 2009 Jun; 196(2):239-47. PubMed ID: 19040709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of the hypophysis in the renal responses upon stimulation of the brain osmoreceptor].
    He XR; Shi L; Wang WH; Yao T
    Sheng Li Xue Bao; 1992 Jun; 44(3):215-21. PubMed ID: 1455253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction.
    Mulinari RA; Gavras I; Wang YX; Franco R; Gavras H
    Circulation; 1990 Jan; 81(1):308-11. PubMed ID: 2404626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.